adminph

Heather Knight

February 18, 2025 0

Baxter has appointed Heather Knight as Executive Vice President and COO Baxter International has appointed Heather Knight, who has been...

Common drug shows promise against rare type of heart disease

February 18, 2025 0

A research team co-led by scientists at the University of Arizona College of Medicine - Tucson found that an osteoporosis...

Cambridge scientists develop ‘super test’ for prostate cancer

February 17, 2025

New test aims to revolutionise prostate cancer screening Scientists in Cambridge have developed a new ‘super test’ for prostate cancer...

Bath researchers awarded Wellcome grant for psychotic disorder study

February 17, 2025

New funding to investigate cognitive decline and brain ageing The University of Bath has received a £3.5 million Wellcome grant...

NUS Medicine pioneers ground-breaking technique to deliver drugs directly to the brain

February 17, 2025 0

Scientists at the Yong Loo Lin School of Medicine, National University of Singapore (NUS Medicine) have developed a ground-breaking technique...

An enzyme to disarm tumors

February 14, 2025 0

When a tumour develops, it creates a structure around itself called the tumour stroma, within which blood and lymphatic vessels...

Andembry treatment approved across Europe

February 13, 2025

Significant progress for hereditary angioedema condition Global biotechnology leader CSL has announced that the European Commission (EC) has approved ANDEMBRY...

Illuccix therapy gets approval in the UK

February 13, 2025

Imaging agent to improve prostate cancer detection Telix Pharmaceuticals has announced that the UK’s Medicines and Healthcare Products Regulatory Agency...

PanK4 identified as a regulator of glucose and lipid metabolism

February 13, 2025 0

Physical activity is not only important for fitness, but also for health. This is confirmed by a new study conducted...

Amlenetug receives FDA Fast Track Designation

February 12, 2025

Potential treatment for multiple system atrophy shows promise Lundbeck’s investigational drug, amlenetug, has been granted Fast Track Designation by the...

Bimekizumab shows long-term efficacy in hidradenitis suppurativa

February 12, 2025

UCB's BIMZELX reveals promising two-year data at EHSF 2025 UCB has announced impressive two-year data for BIMZELX (bimekizumab) at the...

Why antibiotics can fail even against non-resistant bacteria

February 12, 2025 0

Antibiotics are indispensable for treating bacterial infections. But why are they sometimes ineffective, even when the bacteria are not resistant?...

Libtayo available in Scotland for cervical cancer patients

February 11, 2025

New immunotherapy offers hope for recurrent cervical cancer Regeneron UK Limited has announced that the Scottish Medicines Consortium (SMC) has...

Lynparza approved in Scotland for BRCA-mutated breast cancer patients

February 11, 2025

Treatment expands options for HER2-negative metastatic breast cancer AstraZeneca announced that its drug Lynparza (olaparib) has been approved for use...

New treatment offers quick cure for common cause of high blood pressure

February 11, 2025 0

Doctors at Queen Mary University of London, Barts Health NHS Trust, and University College London have led the development of...

Capgemini unveils AI breakthrough to boost bioeconomy

February 10, 2025

New methodology may boost innovation in protein engineering Capgemini has introduced a pioneering generative AI-driven methodology for protein engineering, utilising...

Hemgenix shows efficacy among haemophilia B patients

February 10, 2025

CSL Behring's study reveals significant long-term benefits New data from CSL Behring’s HOPE-B study demonstrates that Hemgenix (etranacogene dezaparvovec-drlb) gene...